CRISTINA R DENAPOLES

Physician Assistants & Advanced Practice Nursing Providers|Nurse Practitioner|Family PENSACOLA, FL NPI 1467971192

General Payments — all program years on this page

$1,373.71

  • Category: General Payments
  • Program years: PY2021–2024
  • Record count: 81
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $286.35 across 16 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $286.3516

By paying entity

Latest program year (PY2024) · sorted by reported total.

Paying entityAmountRecords
Novo Nordisk AS $182.4910
Acerta Pharma LLC $40.612
Lilly USA, LLC $34.362
Exact Sciences Corporation $15.051
Esperion Therapeutics, Inc. $13.841

By program year

Program yearAmountRecords
2021 $540.1431
2022 $253.1817
2023 $294.0417
2024 $286.3516

Records — PY2024 (16)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1100230418 Novo Nordisk Inc $18.39 04/08/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1100232430 Novo Nordisk Inc $21.31 06/24/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1100313239 Novo Nordisk Inc $14.20 04/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1100386717 Novo Nordisk Inc $23.00 05/14/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1100445001 Novo Nordisk Inc $17.95 08/27/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1100503745 Novo Nordisk Inc $23.75 03/21/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1100517279 Novo Nordisk Inc $14.68 08/26/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1100552922 Novo Nordisk Inc $15.79 03/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1100654439 Novo Nordisk Inc $17.57 06/24/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1100657994 Novo Nordisk Inc $15.85 01/30/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104501280 AstraZeneca Pharmaceuticals LP $22.09 04/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104679879 AstraZeneca Pharmaceuticals LP $18.52 05/06/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1114552348 Exact Sciences Corporation $15.05 07/15/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1129465140 Esperion Therapeutics, Inc. $13.84 07/01/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135546839 Lilly USA, LLC $17.66 02/29/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135596204 Lilly USA, LLC $16.70 05/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.